CI-966

N/A

Report date: 2022/01/14 13:23:58

NME

Base Information

Drug NameCI-966

Drug Alias NameCI 966CI-966PD-126141PD 126141

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionGABA uptake inhibitors

TargetsGABA transporter 1

Therapy Area/IndicationsEpilepsy

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesPfizer Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesPfizer Inc

Active IndicationsN/A

Inactive IndicationsEpilepsy

ATC CodeN/A